Forbes -
14 Jan 2015 18:36
In trading on Wednesday, the SPDR S&P Biotech ETF (XBI) is outperforming other ETFs, up about 0.9% on the day. Components of that ETF showing particular strength include shares of Ziopharm Oncology (ZIOP), up about 55% and shares of Intrexon (XON), up about 20.3% on the day.
Share this Article
Comment on this Article
Please to comment